Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Tischkowitz

Showing results (81-90 of 258) with videos related to

Pageof 26
Sort By:
Blood|January 20, 2005
A common Fanconi anemia mutation in black populations of sub-Saharan AfricaNeil V Morgan, Fahmida Essop, Ilja Demuth, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 18, 2020
CanRisk Tool-A Web Interface for the Prediction of Breast and Ovarian Cancer Risk and the Likelihood of Carrying Genetic Pathogenic VariantsTim Carver, Simon Hartley, Andrew Lee, et al.
Gastrointestinal Endoscopy|July 10, 2017
Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation statusEmma Z Mi, Ella Z Mi, Massimiliano di Pietro, et al.
Genes|October 29, 2025
Familial <i>NSD1</i> Exon 3 Deletion Associated with Phenotypic and Epigenetic VariabilitySunwoo Liv Lee, Alison Foster, Dalit May, et al.
BJC Reports|February 3, 2026
Implementing mainstream germline genetic testing in breast cancer across EuropeEduard Pérez-Ballestero, Sagal Ahmed Shire, Mateja Krajc, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 25, 2023
Management of individuals with germline pathogenic/likely pathogenic variants in CHEK2: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)Helen Hanson, Esteban Astiazaran-Symonds, Laura M Amendola, et al.
Plos One|March 7, 2020
Evaluating clinician acceptability of the prototype CanRisk tool for predicting risk of breast and ovarian cancer: A multi-methods studyStephanie Archer, Chantal Babb de Villiers, Fiona Scheibl, et al.
Genes, Chromosomes & Cancer|January 17, 2020
Characterization of renal cell carcinoma-associated constitutional chromosome abnormalities by genome sequencingPhilip S Smith, James Whitworth, Hannah West, et al.
Familial Cancer|June 18, 2017
Use of the BOADICEA Web Application in clinical practice: appraisals by clinicians from various countriesAnne Brédart, Jean-Luc Kop, Antonis C Antoniou, et al.
BMC Medical Genomics|November 12, 2013
Hi-Plex for high-throughput mutation screening: application to the breast cancer susceptibility gene PALB2Tú Nguyen-Dumont, Zhi L Teo, Bernard J Pope, et al.
Pageof 26

Showing results (81-90 of 258) with videos related to

Sort By:
Pageof 26
Blood|January 20, 2005
A common Fanconi anemia mutation in black populations of sub-Saharan AfricaNeil V Morgan, Fahmida Essop, Ilja Demuth, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 18, 2020
CanRisk Tool-A Web Interface for the Prediction of Breast and Ovarian Cancer Risk and the Likelihood of Carrying Genetic Pathogenic VariantsTim Carver, Simon Hartley, Andrew Lee, et al.
Gastrointestinal Endoscopy|July 10, 2017
Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation statusEmma Z Mi, Ella Z Mi, Massimiliano di Pietro, et al.
Genes|October 29, 2025
Familial <i>NSD1</i> Exon 3 Deletion Associated with Phenotypic and Epigenetic VariabilitySunwoo Liv Lee, Alison Foster, Dalit May, et al.
BJC Reports|February 3, 2026
Implementing mainstream germline genetic testing in breast cancer across EuropeEduard Pérez-Ballestero, Sagal Ahmed Shire, Mateja Krajc, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 25, 2023
Management of individuals with germline pathogenic/likely pathogenic variants in CHEK2: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)Helen Hanson, Esteban Astiazaran-Symonds, Laura M Amendola, et al.
Plos One|March 7, 2020
Evaluating clinician acceptability of the prototype CanRisk tool for predicting risk of breast and ovarian cancer: A multi-methods studyStephanie Archer, Chantal Babb de Villiers, Fiona Scheibl, et al.
Genes, Chromosomes & Cancer|January 17, 2020
Characterization of renal cell carcinoma-associated constitutional chromosome abnormalities by genome sequencingPhilip S Smith, James Whitworth, Hannah West, et al.
Familial Cancer|June 18, 2017
Use of the BOADICEA Web Application in clinical practice: appraisals by clinicians from various countriesAnne Brédart, Jean-Luc Kop, Antonis C Antoniou, et al.
BMC Medical Genomics|November 12, 2013
Hi-Plex for high-throughput mutation screening: application to the breast cancer susceptibility gene PALB2Tú Nguyen-Dumont, Zhi L Teo, Bernard J Pope, et al.
Pageof 26